o by : david chamberlain, dan clark, & audra lenczowski
TRANSCRIPT
OBy: David Chamberlain, Dan Clark, & Audra Lenczowski
http://www.dicentral.com/henry_shein_edi/images/Henry_Shein_Inc_edi-edi.gif
http://www.henryschein.com/us-en/images/corporate/history_img1.jpg
Mission StatementO To provide innovative, integrated health care
products and services; and to be trusted advisors and consultants to our customers - enabling them to deliver the best quality patient care and enhance their practice management efficiency and profitability.
O 80 YearsOver 190,000 Products775,000 Customers
HistoryO Henry Schein, pharmacist in 1932 opened a
corner drugstore in Woodside, NY
O By 1940’s company introduces private-brand dental, medical, and veterinary products
O By 1950 offered mail order to MD offices
HistoryO 1964 criminal complaint for selling counterfeit
Dexedrine to 3 out of state pharmacies and illegally selling amphetamine, barbiturates, and PCN tabs to an undercover federal agent
O 1970’s when mail order really took off, and when the family really focused on the dental market
O Sold his pharmacy in the mid 1970’s to become full time distributor of medical/dental and generic drugs. Annual sales at $40 million.
History
O 1980 began automating distribution through telephone or computer
O Within decade was dominant in field and by 1988 controlled more than 40% of mail order market for dental supplies
O 1990 to separate from the rest- started offering computer and financial products to dentist
HistoryO 1990’s cont. Branched out to European markets,
selling through distributor to Mexico and catalog direct to Canada
O Annual sales 1990 was $236.3 million up to $415.7 million in 1993
O Went public Nov 1995 raising $72.5 million from initial offering to $16 a share. July 96 raised an additional $124.1 million by selling more stock at $35 a share.
CurrentlyO Mostly in North America, Europe, New Zealand and
Australia
O Includes- MD practices, dental practices, labs, vet clinics, government and other institutions
O Major groups: dental (33.6% of total net sales), medical (16.6% of total net sales), veterinary health (11.6% of total net sales), international (35.3% of total net sales) and technology (2.9% of total net sales)
Awards & RecognitionO 2012 ranked #303 in Fortune® 500 for
America’s Largest Companies
O Ranked #10 in the Barron’s 500 (ranked based on deploying cash flow and growing business)
O Worlds Most Ethical Companies 2012 by Ethisphere Institute
O Worlds Most Admired Companies by Fortune® 2012
Awards & RecognitionO Henry Schein Dental ranks as one of
Wisconsin’s Top 100 Workplaces in 2012 & 2011
Current Ratio
Henry Schein current ratio for 20X1 and 20X0
Year Current Ratioᵃ = Current Assets / Current Liabilities
20X1 1.79 = $ 2,272,508 / $ 1,271,640
20X0 1.86 = $ 2,169,302 / $ 1,168,087
ᵃBenchmark= 2.0
Acid Test Ratio
Henry Schein acid test ratio for 20X1 and 20X0
YearAcid Test
Ratioᵃ =
(Cash + Marketable /Securities) /
Current Liabilities
20X1 0.12 = $ 147,284 /
$ 1,271,640
20X0 0.13 = $ 150,348 /
$ 1,168,087
ᵃBenchmark= ????
Days in Accts Receivable
Henry Schein Days in Accounts Receivable Ratio for 20X1 and 20X0
Steps 1, 2
YearAverage Net Sales Revenues per Day
=Net Sales Revenues
/ 365 Days
20X1
= $8,530,242 / 365$23,370.53
20X0 $20,621.34 = $7,526,790 / 365
Steps 3, 4
YearDays in Accounts Receivableᵃ
=Net Accounts
Receivable/
Average Net Sales Revenues per /Day
20X1 38 = $888,248 / $23,370.53
20X0 43 = $885,784 / $20,621.34
Average Payment Period
Henry Schein average payment period ratio for 20X1 and 20X0
Steps 1, 2
Year
Average Cash Expense per Day
=(Operating Expenses
-Depreciation & Amortization Expenses)
20X1 $4,712.36 = $1,835,906 - $115,896 20X0 $4,208.89 = $1,637,460 - $101,214 Steps 3, 4
YearAverage Payment Period Daysᵃ
=Current
Liabilities/
Average Cash Expense per Day
20X1 132 = $621,468 / $4,712.36
20X0 140 = $590,029 / $4,208.89
ᵃBenchmark= Unknown
Operating Margin
Henry Schein's operating margin for 20X1 and 20X0
Year Operating Margin =Operating Income
/Total Operating
Revenues
20X1 7% = $582,149 / $8,530,242
20X0 7% = $521,131 / $7,526,790
Return on Total Assets Ratio
Henry Schein return on total assets ratio for 20X1 and 20X0
YearReturn on Total Assetsᵃ = Net Income / Total Assets
20X1 0.078 = $367,661 / $4,740,144
20X0 0.072 = $325,789 / $4,547,471
ᵃBenchmark= ??
Total Asset Turnover Ratio
Henry Schein's Total Asset Turnover Ratio for 20X1 and 20X0
YearTotal Asset Turnover
=Total Operating
Revenues/ Total Assets
20X1 0.51 = $2,418,055 / $4,740,144
20X0 0.48 = $2,170,876 / $4,547,471
Fixed Asset Turnover Ratio
Henry Schein's Fixed Asset Turnover Ratio for 20X1 and 20X0
YearFixed Asset
Turnover=
Total Operating Revenues
/Net Plant & Equipment
20X1 9.22 = $2,418,055 / $262,088
20X0 8.6 = $2,170,876 / $252,573
Long-term Debt to Net Assets Ratio
Henry Schein Corp long-term debt to net assets ratio for 20X1 and 20X0
Year
Long-term Debt to Net Assetsᵃ =
Long-term Debt /
Stockholders Equity
20X1 0.15 = $ 363,524 / $ 2,433,623
20X0 0.16 = $ 395,309 / $ 2,412,957
ᵃBenchmark= ?
Equity to Total Assets Ratio
Henry Schein net assets to total assets ratio for 20X1 and 20X0
YearNet Assets to Total Assetsᵃ =
Stockholders Equity / Total Assets
20X1 0.51 = $ 2,433,623 / $ 4,740,144
20X0 0.53 = $ 2,412,957 / $ 4,547,741
ᵃBenchmark= ?
ConclusionO Henry Schein is the largest supplier
of healthcare products
O At first glance, the 80 year old company looks rock solid
O Its balance sheet has $4.8 billion in assets and only $1.9 billion in liabilities.
ConclusionO 5 notable key weakness include:O 1. Current Ratio = 1.79% (↓0.07)
O To improve increase assets or decrease current liabilities
O 2. Acid Test Ratio = 12% (↓1%) O Not much instantly available cash O Increase cash and marketable
securities or decrease current liabilities
ConclusionO 3. Average payment period ratio =
132 days (↑ 8 days) O 132 to make payments seems
excessive
O 4. Operating margin = 7% (−0%) O Decrease its operating expenses
while growing operating revenue.
ConclusionO 5. Total asset turnover ratio = 0.51
(↑ 0.03) O 2 years to make back invested money
O Very successful company over the years
Questions
Thanks for your time and
attention!
BibliographyHenry Schein | Investor Relations | About Henry Schein. (n.d.). Henry Schein | Investor Relations | Investor Relations. Retrieved January 6, 2013, from http://investor.henryschein.com/phoenix.zhtml?c=74322&p=aboutus&hsi_domain=www.henryschein.com&hsi_locale=us-enSchein, w. b., management, w. a., 1995, d. i., & Corporation, a. i. (n.d.). History of Henry Schein, Inc. – FundingUniverse. Find Funding with Banks, Investors, and Other Funding Sources | FundingUniverse. Retrieved January 6, 2013, from http://www.fundinguniverse.com/company-histories/henry-schein-inc-history/Zelman, W., McCue, M., & Glick, N. (2009). Financial managment of health care organizations. (3rd ed., pp. 1-568). San Francisco, CA: Jossey-Bass